Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | Yet another biotech is facing a delay from the Food and Drug ...

Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...

Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...

Medically reviewed by Nicholas R. Metrus, MD Multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease) are both diseases that affect your central nervous system ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...

SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.

In that moment, things clicked. A year ago, my father died after an absolutely brutal battle with amyotrophic lateral ...

By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...

A brain-computer interface has enabled people with paralysis to turn their thoughts directly into words, requiring less ...

In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined saying.